Page last updated: 2024-11-04

temozolomide and Fasting Hypoglycemia

temozolomide has been researched along with Fasting Hypoglycemia in 1 studies

Fasting Hypoglycemia: HYPOGLYCEMIA expressed in the postabsorptive state, after prolonged FASTING, or an overnight fast.

Research Excerpts

ExcerptRelevanceReference
"Nonislet cell tumor hypoglycemia is rare."6.58Recurrent Severe Hypoinsulinemic Hypoglycemia Responsive to Temozolomide and Bevacizumab in a Patient With Doege-Potter Syndrome. ( Hilsenbeck, HL; Nyenwe, EA; Ogunsakin, AA; Portnoy, DC, 2018)
"Nonislet cell tumor hypoglycemia is rare."2.58Recurrent Severe Hypoinsulinemic Hypoglycemia Responsive to Temozolomide and Bevacizumab in a Patient With Doege-Potter Syndrome. ( Hilsenbeck, HL; Nyenwe, EA; Ogunsakin, AA; Portnoy, DC, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogunsakin, AA1
Hilsenbeck, HL1
Portnoy, DC1
Nyenwe, EA1

Reviews

1 review available for temozolomide and Fasting Hypoglycemia

ArticleYear
Recurrent Severe Hypoinsulinemic Hypoglycemia Responsive to Temozolomide and Bevacizumab in a Patient With Doege-Potter Syndrome.
    The American journal of the medical sciences, 2018, Volume: 356, Issue:2

    Topics: Bevacizumab; Female; Fibroma; Humans; Hypoglycemia; Middle Aged; Pleural Neoplasms; Temozolomide

2018